Live Breaking News & Updates on Iowa Bioventures Center

Stay updated with breaking news from Iowa bioventures center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Announces Closing of Its Series A Financing with Proceeds of $13 Million


Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Announces Closing of Its Series A Financing with Proceeds of $13 Million
??
-NET into Phase 1 imaging studies beginning in 2021 and accelerate development of radioisotope production technologies
CORALVILLE, IA / ACCESSWIRE / January 8, 2021 / Viewpoint Molecular Targeting, Inc. ( Viewpoint or the Company ), a radiopharmaceutical company developing precision α-particle oncology
therapeutics and complementary diagnostic imaging agents, announced today it has closed the third and final tranche of its Series A financing for a total of approximately $13 million. Proceeds from the financing will be used to advance the Company s two lead programs, VMT01 and VMT-??-NET, into Phase 1 human clinical studies, further develop its proprietary VMT-??-GEN isotope generator, and fund general operating expenses. ....

Jenene Thomas , Kostenloser Wertpapierhandel , Michaelk Schultz , Frances Johnson , University Of Iowa , Viewpoint Molecular Targeting Inc , University Of Iowa Bioventures Center , Viewpoint Molecular Targeting , Chief Medical Officer , Chief Science Officer , Iowa Bioventures Center , Molecular Targeting , பிரான்சிஸ் ஜான்சன் , பல்கலைக்கழகம் ஆஃப் ஐயுவா , தலைமை மருத்துவ அதிகாரி , தலைமை அறிவியல் அதிகாரி ,